Sweeping Decisions in Health: Vaccines, Drugs, and Rights

The USDA considers vaccinating poultry for bird flu, while the EU supports Madrigal's liver drug Rezdiffra. Meanwhile, the U.S. Supreme Court upheld Tennessee's ban on gender-affirming care for adolescents. Brazil, though, declared bird flu resolved in commercial farms, boosting its poultry export status.


Devdiscourse News Desk | Updated: 21-06-2025 10:26 IST | Created: 21-06-2025 10:26 IST
Sweeping Decisions in Health: Vaccines, Drugs, and Rights
This image is AI-generated and does not depict any real-life event or location. It is a fictional representation created for illustrative purposes only.

The U.S. Department of Agriculture is weighing a historic decision to vaccinate poultry against bird flu. This consideration includes assessing potential impacts on exports, following a devastating outbreak that led to culling millions of birds. The USDA is responding to proposals from egg and turkey producers affected by the virus.

In Europe, the drug regulator has backed conditional authorization for Madrigal Pharmaceuticals' Rezdiffra, setting the stage for it to become the first approved treatment for fatty liver disease in the region. This follows its approval in the United States last year, addressing a significant treatment gap in the EU.

On the legal front, the U.S. Supreme Court upheld a Tennessee law banning gender-affirming care for minors, a decision seen as a setback for transgender rights. However, legal experts note that it leaves room for further challenges. Meanwhile, Brazil declared its bird flu outbreak resolved, solidifying its status as a leading poultry exporter.

(With inputs from agencies.)

Give Feedback